PARTNERSHIP OPPORTUTIES
Establish Your Brand at the Longest Standing Industry Focused Meeting
The Claudin-Targeted Therapies Summit is uniquely positioned as the only industry-specific event focusing exclusively on Claudin-targeted drug development, offering a deep dive into the entire spectrum of these therapies from discovery to early clinical development.
Unlike broader oncology conferences, this summit will bring together top experts from leading companies like AstraZeneca, Astellas, Transcenta, Xencor and Innovent Biologics taking advantage of claudin’s clinical validation to bring more effective and safer claudin-based treatments to patients with unmet medical needs in gastrointestinal, pancreatic, ovarian cancers, and beyond.
As claudin continues to receive more investment from biopharma and become one of oncology’s hottest therapeutic targets, partnering with this event provides an unparalleled opportunity to showcase your expertise and connect with key decision-makers driving the future of Claudin-targeted oncology therapies
Elevate Your Brand in the Claudin Market
Capitalize on the first-ever summit dedicated to Claudin-targeted therapies. By partnering, you can raise your brand awareness in this specialized field, positioning your company as a leader in the development of cutting-edge oncology treatments including gastrointestinal, pancreatic and ovarian oncology treatments.
Distinguish Yourself Through Thought Leadership
Stand out in this competitive space by showcasing your clinical recruitment capabilities, novel biomarkers and specialized assays. Lead discussions, present case studies, and demonstrate your innovative approaches to a focused audience of industry experts
Forge Strategic Alliances with Industry Leaders
Network with key decision-makers from top biopharma companies like AstraZeneca, Astellas, Integral Molecular, Xencor and many more. Generate commercial opportunities and collaborate on the next wave of Claudin-targeted therapies, driving forward the future of cancer treatment.
What Services are Claudin Biopharma Seeking?
Preclinical CROs: with sessions focusing on in vitro and in vivo testing, you can position your services as essential to optimizing drug candidates before they advance to clinical trials. Highlight your unique methodologies and success stories to attract partnerships and collaborations with leading biopharma companies
Assay Providers: leverage this unique forum to present cutting-edge advancements in diagnostic and therapeutic assays specific to Claudin proteins. Connect with key decision-makers who are looking for precise and reliable assays to measure Claudin expression, monitor therapeutic efficacy, and support drug development. This is your chance to demonstrate how your assays can accelerate the development and clinical success of Claudin-targeted therapies
Companion Diagnostic & Biomarker Services: position yourself as leaders in precision medicine by leading conversation on patient stratification and the development of claudin companion diagnostics. The summit's focus on identifying and validating biomarkers for Claudin proteins offers a prime opportunity to showcase your role in enhancing patient selection and improving clinical outcomes
Clinical CROs: engage with potential clients who are seeking comprehensive trial management services, from patient recruitment to data analysis. In an increasingly competitive and international space, use this opportunity to discuss your experience in navigating the regulatory landscape and ensuring compliance for claudin clinical development
Who You Will Meet:
